Mostrando 3 resultados de: 3
Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine
ArticleAbstract: The phosphoramidate triester prodrugs of anti-human HIV 2',3'- dideoxynucleoside analogs (ddN) reprePalabras claves:Autores:Antonio Salgado, Balzarini J., Cahard D., De Clercq E., McGuigan C., Naesens L., Pathirana R., Saboulard D., Velázquez S.Fuentes:scopusNovel nucleoside phosphoramidates as inhibitors of HIV: Studies on the stereochemical requirements of the phosphoramidate amino acid
ArticleAbstract: Novel phosphoramidate derivatives of the anti-HIV nucleoside analogue d4T were designed to act as laPalabras claves:d4T, hiv, Nucleotide, Phosphoramidate, Prodrug, Reverse transcriptaseAutores:Antonio Salgado, Balzarini J., De Clercq E., Harries T.Y., McGuigan C., Yarnold C.J.Fuentes:scopusPhosphoramidate derivatives of d4T as inhibitors of HIV: The effect of amino acid variation
ArticleAbstract: Phosphoramidate derivatives of the nucleoside analogue, 2',3'-dideoxy-2',3'-didehydro thymidine (d4TPalabras claves:2',3'-Dideoxy-2',3'-didehydro thymidine, hiv, Nucleotide, Phosphoramidate, Pro-drugAutores:Antonio Salgado, Balzarini J., Bidois L., Cahard D., De Clercq E., McGuigan C., Naesens L., Tsang H.W., Turner K., Velázquez S.Fuentes:scopus